Long-Term Monitoring Protocols for Bispecific Therapy Complications

Opinion
Video

Panelists discuss how community practices implement protocols and processes to monitor and manage potential long-term complications or adverse events associated with bispecific therapy, focusing on patient follow-up, adverse event reporting, and ongoing risk assessment.

  • What protocols and processes do you have in place at the community practice to continue monitoring and managing potential long-term complications or adverse events associated with bispecific therapy?
Recent Videos
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series
A panel of 5 experts on multiple myeloma
4 KOLs are featured in this series
4 KOLs are featured in this series.
4 KOLs are featured in this series.
Related Content